Want to see XTLB full AI Analyst Report?

XTL Biopharmaceuticals Sponsored ADR (XTLB) Financial Statements

145 Followers

XTL Biopharmaceuticals Sponsored ADR Financial Overview

XTL Biopharmaceuticals Sponsored ADR's market cap is currently $6.26M. The company's EPS TTM is $-11.52; its P/E ratio is -0.82; XTL Biopharmaceuticals Sponsored ADR is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 0.00	$ 451.00K	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 3.00K	$ 0.00	$ -1.00K	$ -1.00K
Operating Income	$ -1.69M	$ -2.17M	$ -765.00K	$ -880.00K	$ -1.03M
EBITDA	$ -752.00K	$ -930.00K	$ -764.00K	$ -879.00K	$ -1.03M
Net Income	$ -6.97M	$ -1.03M	$ -1.78K	$ -1.35M	$ 435.00K
Balance Sheet
Cash & Short-Term Investments	$ 144.00K	$ 1.14M	$ 2.01M	$ 3.72M	$ 6.13M
Total Assets	$ 166.00K	$ 8.55M	$ 2.43M	$ 4.19M	$ 6.62M
Total Debt	$ 269.00K	$ 138.00K	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ 193.00K	$ -233.00K	$ -1.40M	$ -2.09M	$ -2.97M
Total Liabilities	$ 420.00K	$ 3.12M	$ 206.00K	$ 187.00K	$ 1.28M
Stockholders' Equity	$ -254.00K	$ 5.43M	$ 2.22M	$ 4.00M	$ 5.33M
Cash Flow
Free Cash Flow	$ -1.02M	$ -1.67M	$ -707.00K	$ -901.00K	$ -1.05M
Operating Cash Flow	$ -1.02M	$ -1.62M	$ -707.00K	$ -901.00K	$ -1.05M
Investing Cash Flow	$ 522.00K	$ -844.00K	$ 41.00K	$ 36.00K	$ 8.00K
Financing Cash Flow	$ 208.00K	$ 1.45M	$ 0.00	$ 0.00	$ 385.00K

Currency in USD

XTL Biopharmaceuticals Sponsored ADR Earnings and Revenue History

Income Statement >

XTL Biopharmaceuticals Sponsored ADR Debt to Assets

Balance Sheet >

XTL Biopharmaceuticals Sponsored ADR Cash Flow

Cash Flow >

XTL Biopharmaceuticals Sponsored ADR Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >